Pharma & Healthcare
Global Recombinant Human Endostatin Market Research Report 2024
- Mar 19, 24
- ID: 5814
- Pages: 72
- Figures: 151
- Views: 37
Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294.
The global Recombinant Human Endostatin market was valued at US$ 130 million in 2023 and is anticipated to reach US$ 238 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The market for recombinant human endostatin is important in cancer treatment. Trends include research into combination therapies and targeted cancer treatments.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Endostatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Endostatin.
Report Scope
The Recombinant Human Endostatin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Endostatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Endostatin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PeproTech
Segment by Type
Purity:95%
Others
Segment by Application
Medical Care
Scientific Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Endostatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Endostatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Recombinant Human Endostatin market was valued at US$ 130 million in 2023 and is anticipated to reach US$ 238 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The market for recombinant human endostatin is important in cancer treatment. Trends include research into combination therapies and targeted cancer treatments.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Endostatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Endostatin.
Report Scope
The Recombinant Human Endostatin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Endostatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Endostatin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PeproTech
Segment by Type
Purity:95%
Others
Segment by Application
Medical Care
Scientific Research
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Endostatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Endostatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Recombinant Human Endostatin Market Overview
1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Recombinant Human Endostatin Segment by Type
1.2.1 Global Recombinant Human Endostatin Market Value Comparison by Type (2024-2030)
1.2.2 Purity:95%
1.2.3 Others
1.3 Recombinant Human Endostatin Segment by Application
1.3.1 Global Recombinant Human Endostatin Market Value by Application: (2024-2030)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Recombinant Human Endostatin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Endostatin Revenue 2019-2030
1.4.2 Global Recombinant Human Endostatin Sales 2019-2030
1.4.3 Global Recombinant Human Endostatin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Endostatin Market Competition by Manufacturers
2.1 Global Recombinant Human Endostatin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Endostatin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Endostatin Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Human Endostatin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Endostatin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Endostatin, Product Type & Application
2.7 Recombinant Human Endostatin Market Competitive Situation and Trends
2.7.1 Recombinant Human Endostatin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Endostatin Players Market Share by Revenue
2.7.3 Global Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Human Endostatin Retrospective Market Scenario by Region
3.1 Global Recombinant Human Endostatin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Endostatin Global Recombinant Human Endostatin Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Endostatin Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Endostatin Sales by Region: 2025-2030
3.3 Global Recombinant Human Endostatin Global Recombinant Human Endostatin Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Endostatin Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Endostatin Revenue by Region: 2025-2030
3.4 North America Recombinant Human Endostatin Market Facts & Figures by Country
3.4.1 North America Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Endostatin Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Endostatin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Human Endostatin Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Endostatin Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Endostatin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Endostatin Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Endostatin Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Human Endostatin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Human Endostatin Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Endostatin Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Endostatin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Endostatin Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Endostatin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Endostatin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Human Endostatin Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Endostatin Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Endostatin Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Endostatin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Endostatin Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Endostatin Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Endostatin Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Endostatin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Endostatin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Endostatin Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Endostatin Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Endostatin Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Endostatin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Endostatin Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Endostatin Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Endostatin Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Endostatin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Endostatin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 PeproTech
6.2.1 PeproTech Corporation Information
6.2.2 PeproTech Description and Business Overview
6.2.3 PeproTech Recombinant Human Endostatin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PeproTech Recombinant Human Endostatin Product Portfolio
6.2.5 PeproTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Endostatin Industry Chain Analysis
7.2 Recombinant Human Endostatin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Endostatin Production Mode & Process
7.4 Recombinant Human Endostatin Sales and Marketing
7.4.1 Recombinant Human Endostatin Sales Channels
7.4.2 Recombinant Human Endostatin Distributors
7.5 Recombinant Human Endostatin Customers
8 Recombinant Human Endostatin Market Dynamics
8.1 Recombinant Human Endostatin Industry Trends
8.2 Recombinant Human Endostatin Market Drivers
8.3 Recombinant Human Endostatin Market Challenges
8.4 Recombinant Human Endostatin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Recombinant Human Endostatin Segment by Type
1.2.1 Global Recombinant Human Endostatin Market Value Comparison by Type (2024-2030)
1.2.2 Purity:95%
1.2.3 Others
1.3 Recombinant Human Endostatin Segment by Application
1.3.1 Global Recombinant Human Endostatin Market Value by Application: (2024-2030)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Recombinant Human Endostatin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Endostatin Revenue 2019-2030
1.4.2 Global Recombinant Human Endostatin Sales 2019-2030
1.4.3 Global Recombinant Human Endostatin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Endostatin Market Competition by Manufacturers
2.1 Global Recombinant Human Endostatin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Endostatin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Endostatin Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Human Endostatin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Endostatin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Endostatin, Product Type & Application
2.7 Recombinant Human Endostatin Market Competitive Situation and Trends
2.7.1 Recombinant Human Endostatin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Endostatin Players Market Share by Revenue
2.7.3 Global Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Human Endostatin Retrospective Market Scenario by Region
3.1 Global Recombinant Human Endostatin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Endostatin Global Recombinant Human Endostatin Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Endostatin Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Endostatin Sales by Region: 2025-2030
3.3 Global Recombinant Human Endostatin Global Recombinant Human Endostatin Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Endostatin Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Endostatin Revenue by Region: 2025-2030
3.4 North America Recombinant Human Endostatin Market Facts & Figures by Country
3.4.1 North America Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Endostatin Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Endostatin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Human Endostatin Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Endostatin Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Endostatin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Endostatin Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Endostatin Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Human Endostatin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Human Endostatin Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Endostatin Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Endostatin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Endostatin Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Endostatin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Endostatin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Endostatin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Human Endostatin Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Endostatin Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Endostatin Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Endostatin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Endostatin Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Endostatin Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Endostatin Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Endostatin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Endostatin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Endostatin Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Endostatin Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Endostatin Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Endostatin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Endostatin Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Endostatin Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Endostatin Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Endostatin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Endostatin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 PeproTech
6.2.1 PeproTech Corporation Information
6.2.2 PeproTech Description and Business Overview
6.2.3 PeproTech Recombinant Human Endostatin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PeproTech Recombinant Human Endostatin Product Portfolio
6.2.5 PeproTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Endostatin Industry Chain Analysis
7.2 Recombinant Human Endostatin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Endostatin Production Mode & Process
7.4 Recombinant Human Endostatin Sales and Marketing
7.4.1 Recombinant Human Endostatin Sales Channels
7.4.2 Recombinant Human Endostatin Distributors
7.5 Recombinant Human Endostatin Customers
8 Recombinant Human Endostatin Market Dynamics
8.1 Recombinant Human Endostatin Industry Trends
8.2 Recombinant Human Endostatin Market Drivers
8.3 Recombinant Human Endostatin Market Challenges
8.4 Recombinant Human Endostatin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Recombinant Human Endostatin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Human Endostatin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Human Endostatin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Human Endostatin Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Human Endostatin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Endostatin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Endostatin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Human Endostatin Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Human Endostatin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Endostatin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Endostatin, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Endostatin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Endostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Endostatin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Endostatin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Human Endostatin Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Recombinant Human Endostatin Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Human Endostatin Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Recombinant Human Endostatin Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Human Endostatin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Human Endostatin Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Human Endostatin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Human Endostatin Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Endostatin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Human Endostatin Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Recombinant Human Endostatin Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Recombinant Human Endostatin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Endostatin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Human Endostatin Sales (K Pcs) by Type (2019-2024)
Table 51. Global Recombinant Human Endostatin Sales (K Pcs) by Type (2025-2030)
Table 52. Global Recombinant Human Endostatin Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Human Endostatin Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Human Endostatin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Human Endostatin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Human Endostatin Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Human Endostatin Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Human Endostatin Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Recombinant Human Endostatin Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Recombinant Human Endostatin Sales (K Pcs) by Application (2019-2024)
Table 61. Global Recombinant Human Endostatin Sales (K Pcs) by Application (2025-2030)
Table 62. Global Recombinant Human Endostatin Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Human Endostatin Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Human Endostatin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Human Endostatin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Human Endostatin Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Human Endostatin Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Human Endostatin Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Recombinant Human Endostatin Price (USD/Pcs) by Application (2025-2030)
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Recombinant Human Endostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Thermo Fisher Scientific Recombinant Human Endostatin Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. PeproTech Corporation Information
Table 76. PeproTech Description and Business Overview
Table 77. PeproTech Recombinant Human Endostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. PeproTech Recombinant Human Endostatin Product
Table 79. PeproTech Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Recombinant Human Endostatin Distributors List
Table 83. Recombinant Human Endostatin Customers List
Table 84. Recombinant Human Endostatin Market Trends
Table 85. Recombinant Human Endostatin Market Drivers
Table 86. Recombinant Human Endostatin Market Challenges
Table 87. Recombinant Human Endostatin Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Human Endostatin
Figure 2. Global Recombinant Human Endostatin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Human Endostatin Market Share by Type in 2023 & 2030
Figure 4. Purity:95% Product Picture
Figure 5. Others Product Picture
Figure 6. Global Recombinant Human Endostatin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Human Endostatin Market Share by Application in 2023 & 2030
Figure 8. Medical Care
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Global Recombinant Human Endostatin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Human Endostatin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Human Endostatin Sales (2019-2030) & (K Pcs)
Figure 14. Global Recombinant Human Endostatin Average Price (USD/Pcs) & (2019-2030)
Figure 15. Recombinant Human Endostatin Report Years Considered
Figure 16. Recombinant Human Endostatin Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Human Endostatin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Recombinant Human Endostatin Players: Market Share by Revenue in 2023
Figure 19. Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Human Endostatin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Human Endostatin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Human Endostatin Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Recombinant Human Endostatin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Human Endostatin by Type (2019-2030)
Figure 56. Global Recombinant Human Endostatin Price (USD/Pcs) by Type (2019-2030)
Figure 57. Global Sales Market Share of Recombinant Human Endostatin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Recombinant Human Endostatin by Application (2019-2030)
Figure 59. Global Recombinant Human Endostatin Price (USD/Pcs) by Application (2019-2030)
Figure 60. Recombinant Human Endostatin Value Chain
Figure 61. Recombinant Human Endostatin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Recombinant Human Endostatin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Human Endostatin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Human Endostatin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Human Endostatin Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Human Endostatin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Endostatin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Endostatin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Human Endostatin Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Human Endostatin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Endostatin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Endostatin, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Endostatin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Endostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Endostatin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Endostatin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Human Endostatin Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Recombinant Human Endostatin Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Human Endostatin Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Recombinant Human Endostatin Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Human Endostatin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Human Endostatin Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Human Endostatin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Human Endostatin Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Endostatin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Human Endostatin Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Recombinant Human Endostatin Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Recombinant Human Endostatin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Endostatin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Human Endostatin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Human Endostatin Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Recombinant Human Endostatin Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Recombinant Human Endostatin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Human Endostatin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Human Endostatin Sales (K Pcs) by Type (2019-2024)
Table 51. Global Recombinant Human Endostatin Sales (K Pcs) by Type (2025-2030)
Table 52. Global Recombinant Human Endostatin Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Human Endostatin Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Human Endostatin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Human Endostatin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Human Endostatin Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Human Endostatin Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Human Endostatin Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Recombinant Human Endostatin Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Recombinant Human Endostatin Sales (K Pcs) by Application (2019-2024)
Table 61. Global Recombinant Human Endostatin Sales (K Pcs) by Application (2025-2030)
Table 62. Global Recombinant Human Endostatin Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Human Endostatin Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Human Endostatin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Human Endostatin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Human Endostatin Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Human Endostatin Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Human Endostatin Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Recombinant Human Endostatin Price (USD/Pcs) by Application (2025-2030)
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Recombinant Human Endostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Thermo Fisher Scientific Recombinant Human Endostatin Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. PeproTech Corporation Information
Table 76. PeproTech Description and Business Overview
Table 77. PeproTech Recombinant Human Endostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. PeproTech Recombinant Human Endostatin Product
Table 79. PeproTech Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Recombinant Human Endostatin Distributors List
Table 83. Recombinant Human Endostatin Customers List
Table 84. Recombinant Human Endostatin Market Trends
Table 85. Recombinant Human Endostatin Market Drivers
Table 86. Recombinant Human Endostatin Market Challenges
Table 87. Recombinant Human Endostatin Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Human Endostatin
Figure 2. Global Recombinant Human Endostatin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Human Endostatin Market Share by Type in 2023 & 2030
Figure 4. Purity:95% Product Picture
Figure 5. Others Product Picture
Figure 6. Global Recombinant Human Endostatin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Human Endostatin Market Share by Application in 2023 & 2030
Figure 8. Medical Care
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Global Recombinant Human Endostatin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Human Endostatin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Human Endostatin Sales (2019-2030) & (K Pcs)
Figure 14. Global Recombinant Human Endostatin Average Price (USD/Pcs) & (2019-2030)
Figure 15. Recombinant Human Endostatin Report Years Considered
Figure 16. Recombinant Human Endostatin Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Human Endostatin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Recombinant Human Endostatin Players: Market Share by Revenue in 2023
Figure 19. Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Human Endostatin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Human Endostatin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Human Endostatin Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Recombinant Human Endostatin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Recombinant Human Endostatin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Recombinant Human Endostatin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Recombinant Human Endostatin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Human Endostatin by Type (2019-2030)
Figure 56. Global Recombinant Human Endostatin Price (USD/Pcs) by Type (2019-2030)
Figure 57. Global Sales Market Share of Recombinant Human Endostatin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Recombinant Human Endostatin by Application (2019-2030)
Figure 59. Global Recombinant Human Endostatin Price (USD/Pcs) by Application (2019-2030)
Figure 60. Recombinant Human Endostatin Value Chain
Figure 61. Recombinant Human Endostatin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Vibrating Viscometer Market Insights, Forecast to 2030
Dec 16, 24
Global Specialty Hoses Market Insights, Forecast to 2030
Dec 16, 24
Global Recreational Fiberglass Boat Market Insights, Forecast to 2030
Dec 16, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232